XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 151 filers reported holding XENON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,262,962 | +341.5% | 300,438 | +397.6% | 2.89% | +255.5% |
| Q2 2023 | $2,324,476 | -27.8% | 60,376 | -32.9% | 0.81% | -23.6% |
| Q1 2023 | $3,221,100 | +63.4% | 90,000 | +80.0% | 1.06% | +37.5% |
| Q4 2022 | $1,971,500 | -19.4% | 50,000 | -37.5% | 0.77% | +97.7% |
| Q1 2022 | $2,446,000 | -48.0% | 80,000 | -46.8% | 0.39% | -77.1% |
| Q4 2021 | $4,702,000 | +515.4% | 150,500 | +201.0% | 1.71% | +784.5% |
| Q3 2021 | $764,000 | – | 50,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |